116 related articles for article (PubMed ID: 11718149)
1. Off-label uses of monoclonal antibodies for treatment of B-cell lymphoid or myeloid malignancies.
Tecnologica MAP Suppl; 2001 Jul; ():14-7. PubMed ID: 11718149
[No Abstract] [Full Text] [Related]
2. Off-label uses of trastuzumab.
Tecnologica MAP Suppl; 1999 Apr; ():22-3. PubMed ID: 10848167
[No Abstract] [Full Text] [Related]
3. Special report: maintenance therapy in advanced non-small-cell lung cancer.
Technol Eval Cent Assess Program Exec Summ; 2011 Jul; 26(4):1-3. PubMed ID: 22022747
[No Abstract] [Full Text] [Related]
4. Salvage high-dose chemotherapy with allogeneic stem-cell support for relapse or incomplete remission following high-dose chemotherapy with autologous stem-cell transplantation for hematologic malignancies.
Tecnologica MAP Suppl; 2000 Jun; ():16-9. PubMed ID: 11067684
[No Abstract] [Full Text] [Related]
5. Extracorporeal photopheresis for graft versus host disease or autoimmune disease.
Tecnologica MAP Suppl; 2001 Sep; ():1-8. PubMed ID: 11718151
[No Abstract] [Full Text] [Related]
6. High dose lymphoablative therapy (HDLT) with or without stem cell rescue for treatment of severe autoimmune diseases.
Tecnologica MAP Suppl; 2000 Apr; ():10-2. PubMed ID: 11010674
[No Abstract] [Full Text] [Related]
7. FDA approves new kind of lymphoma treatment. Food and Drug Administration.
James JS; Dubs G
AIDS Treat News; 1997 Dec; (No 284):2-3. PubMed ID: 11364912
[TBL] [Abstract][Full Text] [Related]
8. Intravenous immune globulin for multiple sclerosis.
Tecnologica MAP Suppl; 1998 Aug; ():3-5. PubMed ID: 10342975
[No Abstract] [Full Text] [Related]
9. Graftskin for the treatment of skin ulcers.
Tecnologica MAP Suppl; 2001 Jul; ():10-3. PubMed ID: 11718148
[No Abstract] [Full Text] [Related]
10. High-dose chemotherapy with autologous stem-cell support in the treatment of high-risk, primary breast cancer.
Tecnologica MAP Suppl; 1999 Jan; ():8-10. PubMed ID: 10346740
[No Abstract] [Full Text] [Related]
11. Transcatheter arterial chemoembolization of hepatic tumors.
Tecnologica MAP Suppl; 2000 Dec; ():13-8. PubMed ID: 11503768
[No Abstract] [Full Text] [Related]
12. Phototherapy for the treatment of seasonal affective disorder.
Tecnologica MAP Suppl; 1999 Apr; ():24-6. PubMed ID: 10848168
[No Abstract] [Full Text] [Related]
13. Sacral nerve stimulation for the treatment of urinary urgency/frequency.
Tecnologica MAP Suppl; 2000 Jun; ():12-5. PubMed ID: 11067683
[No Abstract] [Full Text] [Related]
14. Lipid apheresis in the treatment of patients with severe, refractory hypercholesterolemia.
Tecnologica MAP Suppl; 1999 Apr; ():15-7. PubMed ID: 10848165
[No Abstract] [Full Text] [Related]
15. Lymphoma treatment approved.
AIDS Patient Care STDS; 1998 Mar; 12(3):231. PubMed ID: 11361944
[No Abstract] [Full Text] [Related]
16. High-dose chemotherapy with autologous stem-cell support for epithelial ovarian cancer.
Tecnologica MAP Suppl; 1999 Jan; ():5-7. PubMed ID: 10346739
[No Abstract] [Full Text] [Related]
17. Sacral nerve stimulation for the treatment of urge incontinence.
Tecnologica MAP Suppl; 1998 Aug; ():10-3. PubMed ID: 10342977
[No Abstract] [Full Text] [Related]
18. High-dose chemotherapy with autologous stem cell support in the treatment of chronic lymphocytic leukemia or small lymphocytic lymphoma.
Tecnologica MAP Suppl; 2000 Jan; ():17-9. PubMed ID: 10848119
[No Abstract] [Full Text] [Related]
19. Genentech and IDEC await approval of lymphoma Mab.
Nat Biotechnol; 1997 Apr; 15(4):301. PubMed ID: 9094110
[No Abstract] [Full Text] [Related]
20. Becaplermin for wound healing.
Tecnologica MAP Suppl; 1999 Apr; ():8-12. PubMed ID: 10848163
[No Abstract] [Full Text] [Related]
[Next] [New Search]
